Antioxidative effects of fluvastatin and its metabolites against DNA damage in streptozotocin-treated mice (Q44184611)

30 November 2017

title

Antioxidative effects of fluvastatin and its metabolites against DNA damage in streptozotocin-treated mice (English)

1 reference

30 November 2017

Imaeda A

1

1 reference

30 November 2017

Kaneko T

2

1 reference

30 November 2017

Aoki T

3

1 reference

30 November 2017

Kondo Y

4

1 reference

30 November 2017

Nakamura N

5

1 reference

30 November 2017

Nagase H

6

1 reference

30 November 2017

Yoshikawa T

7

1 reference

30 November 2017

publication date

1 October 2002

1 reference

Food and Chemical Toxicology

30 November 2017

published in

1 reference

30 November 2017

volume

40

1 reference

30 November 2017

issue

10

1 reference

30 November 2017

page(s)

1415-1422

1 reference

Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Endogenous oxidative DNA damage, aging, and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

The effects of vitamin C supplementation on biomarkers of oxygen radical generated damage in human volunteers with “low” or “high” cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

The comet assay: a comprehensive review

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Probucol scavenged 1,1-diphenyl-2-picrylhydrazyl radicals and inhibited formation of thiobarbituric acid reactive substances

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Protective effects of fluvastatin against reactive oxygen species induced DNA damage and mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Antioxidative effects of fluvastatin and its metabolites against oxidative DNA damage in mammalian cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

DNA damage and the effect of antioxidants in streptozotocin-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Formation of 8-oxo-2'-deoxyguanosine in the DNA of human diploid fibroblasts by treatment with linoleic acid hydroperoxide and ferric ion.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Non-linear accumulation of 8-hydroxy-2'-deoxyguanosine, a marker of oxidized DNA damage, during aging

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Extent and persistence of streptozotocin-induced DNA damage and cell proliferation in rat kidney as determined by in vivo alkaline elution and BrdUrd labeling assays

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Evaluation of a tissue homogenization technique that isolates nuclei for the in vivo single cell gel electrophoresis (comet) assay: a collaborative study by five laboratories

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Mechanism of antioxidative activity of fluvastatin-determination of the active position

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Detection of chemically induced DNA lesions in multiple mouse organs (liver, lung, spleen, kidney, and bone marrow) using the alkaline single cell gel electrophoresis (Comet) assay

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Tissue-specific induction of mutations by streptozotocin in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Assays for 8-hydroxy-2′-deoxyguanosine: A biomarker of in vivo oxidative DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Superoxide anion scavenging properties of fluvastatin and its metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

An in vitro study of the hydroxyl radical scavenging property of fluvastatin, and HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Protective effect of fluvastatin sodium (XU-62-320), a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, on oxidative modification of human low-density lipoprotein in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Absorption and disposition of fluvastatin, an inhibitor of HMG-CoA reductase, in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Disposition of fluvastatin, an inhibitor of HMG-COA reductase, in mouse, rat, dog, and monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2802%2900111-4

7 January 2021

10.1016/S0278-6915(02)00111-4

Identifiers

DOI

1 reference

release_gswc6itwzfaflpdxfxovj37raa

30 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gswc6itwzfaflpdxfxovj37raa

24 November 2022

mapped directly with Wikidata item

1 reference